Provided by Tiger Trade Technology Pte. Ltd.

Skye Bioscience Inc.

0.7889
+0.03895.19%
Post-market: 0.78960.0007+0.09%19:37 EDT
Volume:242.25K
Turnover:189.53K
Market Cap:26.33M
PE:-0.56
High:0.7999
Open:0.7509
Low:0.7509
Close:0.7500
52wk High:5.75
52wk Low:0.5655
Shares:33.38M
Float Shares:19.88M
Volume Ratio:1.19
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4100
EPS(LYR):-1.4100
ROE:-126.85%
ROA:-71.93%
PB:1.32
PE(LYR):-0.56

Loading ...

Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Correspondence

Form CORRESP - Correspondence